- Home
- SOLS vs ELAN Comparison
SOLS vs ELAN Comparison
Compare SOLS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOLS | ELAN |
|---|---|---|
| Founded | 2025 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SOLS | ELAN |
|---|---|---|
| Price | $78.71 | $25.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $72.75 | $24.89 |
| AVG Volume (30 Days) | 3.1M | ★ 4.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 127.20 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $4,439,000,000.00 |
| Revenue This Year | $6.02 | $7.25 |
| Revenue Next Year | $4.78 | $5.80 |
| P/E Ratio | ★ $54.31 | $279.06 |
| Revenue Growth | N/A | ★ 0.50 |
| 52 Week Low | $40.43 | $8.02 |
| 52 Week High | $84.44 | $26.08 |
Technical Indicators
Market Signals| Indicator | SOLS | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 72.83 | 54.88 |
| Support Level | $75.66 | $24.14 |
| Resistance Level | $83.31 | $25.34 |
| Average True Range (ATR) | 3.83 | 0.75 |
| MACD | 0.90 | -0.06 |
| Stochastic Oscillator | 77.04 | 47.75 |
Price Performance
Historical ComparisonAbout SOLS Solstice Advanced Materials Inc.
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.